4
Changes in Ownership
Avalo Therapeutics, Inc. Filed Acc 0002013869-26-000002
Director acquired 3,166 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Goldman Jonathan Director | 2026-03-28 | Option exercise | +3,166 | 3,166 | D | ||
| Derivatives | |||||||
| Goldman Jonathan Director | 2026-03-28 | Option exercise · Restricted Stock Units | −3,166 | 3,167 | D | ||
Loading xslF345X06/form4-03312026_080309.xml…